109 related articles for article (PubMed ID: 3035879)
1. Postmenopausal osteoporosis: no effect of three years treatment with 1,25-dihydroxycholecalciferol.
Falch JA; Odegaard OR; Finnanger AM; Matheson I
Acta Med Scand; 1987; 221(2):199-204. PubMed ID: 3035879
[TBL] [Abstract][Full Text] [Related]
2. Long-term treatment of postmenopausal osteoporosis with active vitamin D3, 1-alpha-hydroxycholecalciferol (1 alpha-OHD3) and 1, 24 Dihydroxycholecalciferol (1, 24(OH)2D3).
Shiraki M; Orimo H; Ito H; Akiguchi I; Nakao J; Takahashi R; Ishizuka S
Endocrinol Jpn; 1985 Apr; 32(2):305-15. PubMed ID: 2995014
[TBL] [Abstract][Full Text] [Related]
3. Effect of 1,25-dihydroxy-vitamin D3 in itself or combined with hormone treatment in preventing postmenopausal osteoporosis.
Christiansen C; Christensen MS; Rødbro P; Hagen C; Transbøl I
Eur J Clin Invest; 1981 Aug; 11(4):305-9. PubMed ID: 6795047
[TBL] [Abstract][Full Text] [Related]
4. Treatment of post menopausal osteoporosis. A controlled therapeutic trial comparing oestrogen/gestagen, 1,25-dihydroxy-vitamin D3 and calcium.
Jensen GF; Christiansen C; Transbøl I
Clin Endocrinol (Oxf); 1982 May; 16(5):515-24. PubMed ID: 7044620
[TBL] [Abstract][Full Text] [Related]
5. Clinical, biochemical and histological results of a double-blind trial with 1,25-dihydroxyvitamin D3, estradiol and placebo in post-menopausal osteoporosis.
Caniggia A; Delling G; Nuti R; Lorè F; Vattimo A
Acta Vitaminol Enzymol; 1984; 6(2):117-28. PubMed ID: 6388277
[TBL] [Abstract][Full Text] [Related]
6. Importance of alfacalcidol in clinical conditions characterized by high rate of bone loss.
Reginster JY; Lecart MP; Richy F
J Rheumatol Suppl; 2005 Sep; 76():21-5. PubMed ID: 16142847
[TBL] [Abstract][Full Text] [Related]
7. [The effect of 1,25(OH)2D3 on bone mineral content in senile osteoporosis--a dose-finding study].
Shiraki M; Ito H; Orimo H
Nihon Naibunpi Gakkai Zasshi; 1989 Nov; 65(11):1253-63. PubMed ID: 2591609
[TBL] [Abstract][Full Text] [Related]
8. Cost-effectiveness of a fixed dose combination of alendronate and cholecalciferol in the treatment and prevention of osteoporosis in the United Kingdom and The Netherlands.
Jansen JP; Gaugris S; Bergman G; Sen SS
Curr Med Res Opin; 2008 Mar; 24(3):671-84. PubMed ID: 18221588
[TBL] [Abstract][Full Text] [Related]
9. Calcitriol. A review of its use in the treatment of postmenopausal osteoporosis and its potential in corticosteroid-induced osteoporosis.
Dechant KL; Goa KL
Drugs Aging; 1994 Oct; 5(4):300-17. PubMed ID: 7827399
[TBL] [Abstract][Full Text] [Related]
10. Does 1,25(OH)2D3 accelerate spinal bone loss? A controlled therapeutic trial in 70-year-old women.
Jensen GF; Meinecke B; Boesen J; Transbøl I
Clin Orthop Relat Res; 1985; (192):215-21. PubMed ID: 3881203
[TBL] [Abstract][Full Text] [Related]
11. Treatment of postmenopausal osteoporosis with calcitriol or calcium.
Tilyard MW; Spears GF; Thomson J; Dovey S
N Engl J Med; 1992 Feb; 326(6):357-62. PubMed ID: 1729617
[TBL] [Abstract][Full Text] [Related]
12. Effect of a long-term treatment with 1,25-dihydroxyvitamin D3 on osteocalcin in postmenopausal osteoporosis.
Caniggia A; Nuti R; Galli M; Loré F; Turchetti V; Righi GA
Calcif Tissue Int; 1986 Jun; 38(6):328-32. PubMed ID: 3089554
[TBL] [Abstract][Full Text] [Related]
13. Reduced occurrence of vertebral crush fractures in senile osteoporosis treated with 1 alpha (OH)-vitamin D3.
Orimo H; Shiraki M; Hayashi T; Nakamura T
Bone Miner; 1987 Oct; 3(1):47-52. PubMed ID: 3505192
[TBL] [Abstract][Full Text] [Related]
14. Calcitriol treatment is not effective in postmenopausal osteoporosis.
Ott SM; Chesnut CH
Ann Intern Med; 1989 Feb; 110(4):267-74. PubMed ID: 2913914
[TBL] [Abstract][Full Text] [Related]
15. Role of calcitriol in the treatment of postmenopausal osteoporosis.
Aloia JF
Metabolism; 1990 Apr; 39(4 Suppl 1):35-8. PubMed ID: 2182976
[TBL] [Abstract][Full Text] [Related]
16. Calcitriol in the treatment of postmenopausal osteoporosis.
Aloia JF; Vaswani A; Yeh JK; Ellis K; Yasumura S; Cohn SH
Am J Med; 1988 Mar; 84(3 Pt 1):401-8. PubMed ID: 3279769
[TBL] [Abstract][Full Text] [Related]
17. Vitamin D analogs versus native vitamin D in preventing bone loss and osteoporosis-related fractures: a comparative meta-analysis.
Richy F; Schacht E; Bruyere O; Ethgen O; Gourlay M; Reginster JY
Calcif Tissue Int; 2005 Mar; 76(3):176-86. PubMed ID: 15692726
[TBL] [Abstract][Full Text] [Related]
18. Vitamin D and vitamin D analogues for preventing fractures associated with involutional and post-menopausal osteoporosis.
Avenell A; Gillespie WJ; Gillespie LD; O'Connell DL
Cochrane Database Syst Rev; 2005 Jul; (3):CD000227. PubMed ID: 16034849
[TBL] [Abstract][Full Text] [Related]
19. Treatment of postmenopausal osteoporosis.
Nordin BE
Drugs; 1979 Dec; 18(6):484-92. PubMed ID: 391532
[TBL] [Abstract][Full Text] [Related]
20. Effects of calcitriol or calcium on bone mineral density, bone turnover, and fractures in men with primary osteoporosis: a two-year randomized, double blind, double placebo study.
Ebeling PR; Wark JD; Yeung S; Poon C; Salehi N; Nicholson GC; Kotowicz MA
J Clin Endocrinol Metab; 2001 Sep; 86(9):4098-103. PubMed ID: 11549632
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
